Drugs That Affect The Blood Coagulation: Hematologic Agents

  • Uploaded by: dlneisha61
  • 0
  • 0
  • April 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Drugs That Affect The Blood Coagulation: Hematologic Agents as PDF for free.

More details

  • Words: 673
  • Pages: 14
Drugs that Affect the Blood Coagulation

Hematologic Agents

Anticoagulants • • • • •

“prevent thrombus (blood clot) formation” Effective in preventing venous thrombosis Prevent clot formation/extension Do not dissolve clots Increase blood flow to prevent necrosis; interfere with clotting process Most common: Heparin & Coumadin

Heparin sodium • MOA: inhibits conversion of fibrinogen to fibrin by activating antithrombin II = prevents a stable fibrin clot • Indications: • Prophylaxis / Tx of thromboembolic disorders – Deep Vein Thrombosis (DVT) – Pulmonary emboli (PE) • Maintain IV patency (IV flush) • Drug of choice for orthopedic surgeries • Post-op prolonged bed rest (>5days) • Prevents clots r/t artificial heart valves • Treats Disseminated Intravascular Coagulation (DIC) widespread clotting depletes coagulation factors; Heparin slows the process to rebuild factors

Adverse effects • • •

Hemorrhage Thrombocytopenia Pain at injection site

Drug Interactions • Increased risk of bleeding – ASA “antiplatelets” – Thrombolytic agents

• Increased anticoagulant effect •

– Digitalis Long-term use – Alopecia – Osteoporosis

Precautions •Contraindications: »Active hemorrhage »GI ulcers »Liver or kidney disease »Recent eye surgery

Low Molecular Weight Heparins (LMWHs) •enoxaparin (Lovenox) •dalteparin (Fragmin) •No daily monitoring of labs •Uses: – Outpatient therapy – Treats DVT – Ml w/ASA promote cardiac circulation – Complications r/t unstable angina

Nursing Interventions • Health Hx (bleeding disorders or potential risks) • Monitor labs • partial thromboplastin (PTT) PTT is 1.5 - 2.5 times the “normal” value (daily when continuous IV infusion) • Platelet counts

• Assess for bleeding - gums, GI bleed (guaiac + stools) • Admin SC lower abdomen; “No” IM injections • Antidote is Protamine Sulfate for heparin overdose • Nomogram (sliding scale for heparin infusion based on lab studies)

Patient Education • • • • • •

Wear Medic Alert Follow-up appts; labs Notify providers of bleeding Avoid razors Avoid ASA or other antiplatelets Dietary: vitamin K alters effectiveness

warfarin sodium (Coumadin) • MOA: alters the liver’s ability to synthesize Vitamin K dependent clotting factors; no effect on circulating clotting factors or platelet function • Admin orally; effects after 3-5 days • Indications: • Long term prevention of thromboembolic disorders – Deep Vein Thrombosis (DVT) – Pulmonary emboli (PE) • Manage MI to reduce risk of death, recurrent MI

• Contraindications: • Gastric ulcers • Recent eye or spinal cord surgery

Coumadin con’t • • • •

Cramps / nausea with initial dose Begin admin while heparin is being admin IV Antidote is Vitamin K IM for overdose Monitor prothrombin time (PT) 1-1.5 times the normal • Monitor International Normalized Ratio (INR) • Monitor for bleeding • Dietary teaching avoid foods high in vitamin K – leafy green vegetables (spinach, mustard greens etc…)

Antiplatelets prevent arterial thromboembolism • MOA: interfere with initial phase of blood coagulation; inhibits platelet aggregation • Uses: • Prevent MI • Stroke in clients w/ TIA (transient ischemic attacks) • Thromboemboli in pts w/ artificial heart valves

• Adverse effects: • Increased bleeding • GI bleeding, dyspepsia

Important Drugs • ASA • • • •

Analgesic/antipyretic Inhibit prostaglandins Reduces TIA Small doses

• dipyridamole (Persantine) • Recommended for use after cardiac valve replacement admin with Coumadin; dilates coronary arteries

• ticlopidine (Ticlid) • Prevents strokes in person w/ a history of stroke (CVA) who are unable to tolerate ASA

• abciximab (ReoPro) • Admin with percutaneous transluminal coronary (PCTA) angioplasty to prevent rethrombosis; given w/ASA &

Nursing Interventions & Pt. Education • • • • • • • •

Monitor VS routinely EKG Assess for symptoms of stroke Monitor labs bleeding times, CBC q2weeks for 3 months Admin after meals w/full glass of water; antacid to decrease gastric irritation Report tinnitus, unusual bleeding Avoid ETOH use Follow up visits especially during the first 3 months

Thrombolytic agents • • • •

altepase (Activase) streptokinase (Streptase) Meds used to dissolve a preexisting clot Used in acute and emergency situations • Tx MI to re-perfuse myocardium • Reestablish blood flow in arteriovenous cannulas (dialysis) • central venous catheters

• Admin in intensive care units • Lyse (dissolve) thrombi

Related Documents


More Documents from ""